about
Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arraysSerum-dependence of affinity-mediated VEGF release from biomimetic microspheresDesign of growth factor sequestering biomaterialsTargeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells.A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells.Regulating VEGF signaling in platelet concentrates via specific VEGF sequestering.Differential regulation of angiogenesis using degradable VEGF-binding microspheres.Engineering epithelial-stromal interactions in vitro for toxicology assessment.α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.Engineering human cell spheroids to model embryonic tissue fusion in vitro.Specific VEGF sequestering to biomaterials: influence of serum stability.A dimensionless variable for the scale up and transfer of a roller compaction formulation.Development of an organotypic stem cell model for the study of human embryonic palatal fusionThalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansionCharacterizing cleft palate toxicants using ToxCast data, chemical structure, and the biomedical literatureA Three-Dimensional Organoid Culture Model to Assess the Influence of Chemicals on Morphogenetic Fusion
P50
Q28397986-C3A2691A-B409-4FAD-B380-2F0E94341D1BQ33761778-F3AE889C-2757-49EB-9E6E-FE68592C3175Q34543371-747C5002-A3AC-45BF-84B5-B774E5D5281DQ35484964-1CDDC655-8368-4C75-9F99-7C4E0334585DQ35542968-3AF12DAA-45DF-4275-97EE-777DA54F0835Q36528371-61C0F2F1-7B5D-453A-933E-959E83D23CDBQ36840170-6D0FFE85-4B9C-49E2-A3FD-8225466ADC2EQ36899777-981514CE-B47E-4756-8B09-BE40A68BEF6FQ39174572-7E64A3FB-79F7-40EC-9F6E-AA426031B3D4Q40596592-DC135BA7-1B54-436E-926E-465865D9A072Q41229450-9AB25E31-9642-4CF1-A8B1-9F09324476C0Q42049840-A5E848CA-02B1-47CC-AC53-F7DB527226E9Q50935235-60BCF693-7D8E-4484-A319-3A447F6DE5BEQ57801257-306E9DD8-256F-454C-B80C-EEA3280CFE72Q89767252-C85481F2-3B2C-4A51-8BA2-15D0D3B7D4E6Q89833307-48F7389C-9814-4CD6-B0DB-D4DD26C9928BQ93026601-024AAE0B-D95D-4EF7-933C-478CA7301D6DQ93368036-86D895F9-539E-465A-A389-D91A224D2A15
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David G Belair
@ast
David G Belair
@en
David G Belair
@es
David G Belair
@nl
type
label
David G Belair
@ast
David G Belair
@en
David G Belair
@es
David G Belair
@nl
prefLabel
David G Belair
@ast
David G Belair
@en
David G Belair
@es
David G Belair
@nl
P106
P108
P1153
55501782100
57189332987
P21
P31
P496
0000-0003-2145-3829